A Case of Relapsing Polychondritis Improved by Infliximab Treatment
Journal of Rheumatic Diseases
;
: 166-169, 2014.
Article
Dans Coréen
| WPRIM
| ID: wpr-20887
ABSTRACT
Relapsing polychondritis is an episodic, systemic inflammation of the cartilage with unknown autoimmune etiology. It leads to the destruction of cartilaginous structures of the ear, eye, nose, respiratory tract, joints, skin, and heart valve, and its presented symptoms are diverse. It can be improved mainly by corticosteroid or immunosuppressive agents. Recently, the use of biologic agents (TNF inhibitors, rituximab, tocilizumab et al) was reported from abroad. However, there is no reported case of relapsing polychondritis, which is treated by biologic agents in Korea. We report this first case of refractory relapsing polychondritis, which was improved with a treatment of Infliximab.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Polychondrite chronique atrophiante
/
Appareil respiratoire
/
Peau
/
Facteurs biologiques
/
Cartilage
/
Nez
/
Oreille
/
Rituximab
/
Infliximab
/
Valves cardiaques
Pays comme sujet:
Asie
langue:
Coréen
Texte intégral:
Journal of Rheumatic Diseases
Année:
2014
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS